{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:20:38Z","timestamp":1790281238271,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008052","name":"Fundaci\u00f3n Alfonso Mart\u00edn Escudero","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008052","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Instituto de Salud Carlos III, Spain","award":["JR19\/00007"],"award-info":[{"award-number":["JR19\/00007"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238301","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T13:31:53Z","timestamp":1599139913000},"page":"e0238301","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2574-0721","authenticated-orcid":true,"given":"Alvaro","family":"Cobo-Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Blondel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Cavagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Strazielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Ghersi-Egea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Giraudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"pone.0238301.ref001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","article-title":"Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica","volume":"125","author":"T Misu","year":"2013","journal-title":"Acta Neuropathol"},{"key":"pone.0238301.ref002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027412","article-title":"Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema.","volume":"6","author":"J Ratelade","year":"2011","journal-title":"PLoS One."},{"key":"pone.0238301.ref003","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fnins.2015.00390","article-title":"New aspects in fenestrated capillary and tissue dynamics in the sensory circumventricular organs of adult brains.","volume":"9","author":"S Miyata","year":"2015","journal-title":"Front. Neurosci"},{"key":"pone.0238301.ref004","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00401-018-1950-8","article-title":"Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat","volume":"137","author":"S Hillebrand","year":"2019","journal-title":"Acta Neuropathol"},{"key":"pone.0238301.ref005","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1212\/NXI.0000000000000311","article-title":"Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro.","volume":"4","author":"Y Takeshita","year":"2017","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"key":"pone.0238301.ref006","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"T Vincent","year":"2008","journal-title":"J Immunol"},{"key":"pone.0238301.ref007","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jnnp-2011-300434","article-title":"Sera from neuromyelitis optica patients disrupt the blood-brain barrier","volume":"83","author":"F Shimizu","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0238301.ref008","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp-2013-305907","article-title":"Autocrine MMP-2\/9 secretion increases the BBB permeability in neuromyelitis optica","volume":"85","author":"A Tasaki","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0238301.ref009","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/scitranslmed.aai9111","article-title":"Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.","volume":"9","author":"F Shimizu","year":"2017","journal-title":"Sci Transl Med"},{"key":"pone.0238301.ref010","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid.","volume":"4","author":"JJ Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"pone.0238301.ref011","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/acn3.221","article-title":"Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier","volume":"2","author":"N Asgari","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"pone.0238301.ref012","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.24208","article-title":"Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks","volume":"76","author":"DK Sato","year":"2014","journal-title":"Ann Neurol"},{"key":"pone.0238301.ref013","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1212\/WNL.0b013e318296e917","article-title":"Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity","volume":"80","author":"R Marignier","year":"2013","journal-title":"Neurology"},{"key":"pone.0238301.ref014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"DM Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"pone.0238301.ref015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-016-0577-8","article-title":"Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.","volume":"13","author":"R Marignier","year":"2016","journal-title":"J Neuroinflammation"},{"key":"pone.0238301.ref016","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cne.21808","article-title":"Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces","volume":"510","author":"S Gazzin","year":"2008","journal-title":"J Comp Neurol"},{"key":"pone.0238301.ref017","first-page":"e51278","article-title":"Setting-up an in vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport.","volume":"88","author":"Y Molino","year":"2014","journal-title":"J Vis Exp"},{"key":"pone.0238301.ref018","first-page":"291","article-title":"Transport across the choroid plexuses in vivo and in vitro","volume":"89","author":"N Strazielle","year":"2003","journal-title":"Methods Mol Med"},{"key":"pone.0238301.ref019","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: Significance of interleukin-6.","volume":"16","author":"A Uzawa","year":"2010","journal-title":"Mult Scler."},{"key":"pone.0238301.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122000","article-title":"Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.","volume":"10","author":"F Shimizu","year":"2015","journal-title":"PLoS One."},{"key":"pone.0238301.ref021","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.humimm.2013.06.016","article-title":"High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels","volume":"74","author":"PO Barros","year":"2013","journal-title":"Hum Immunol"},{"key":"pone.0238301.ref022","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/STROKEAHA.109.549592","article-title":"Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice","volume":"40","author":"T Sozen","year":"2009","journal-title":"Stroke"},{"key":"pone.0238301.ref023","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.4049\/jimmunol.166.12.7617","article-title":"CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.","volume":"166","author":"BT Fife","year":"2001","journal-title":"J Immunol"},{"key":"pone.0238301.ref024","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000464135","article-title":"Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder","volume":"23","author":"Y Wang","year":"2016","journal-title":"Neuroimmunomodulation"},{"key":"pone.0238301.ref025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.03.020","article-title":"Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks","volume":"421","author":"A Uzawa","year":"2013","journal-title":"Clin Chim Acta"},{"key":"pone.0238301.ref026","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/cei.12733","article-title":"Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.","volume":"183","author":"PO Barros","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"pone.0238301.ref027","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"N Chihara","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0238301.ref028","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","article-title":"Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study","volume":"82","author":"M Araki","year":"2014","journal-title":"Neurology"},{"key":"pone.0238301.ref029","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder","volume":"381","author":"T Yamamura","year":"2019","journal-title":"N Engl J Med"},{"key":"pone.0238301.ref030","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI25141","article-title":"IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis","volume":"115","author":"AI Kaplin","year":"2005","journal-title":"J Clin Invest"},{"key":"pone.0238301.ref031","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/jnc.14446","article-title":"Identification and Quantification of Blood-Brain Barrier Transporters in Isolated Rat Brain Microvessels","volume":"146","author":"H Al Feteisi","year":"2018","journal-title":"J Neurochem"},{"key":"pone.0238301.ref032","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cne.21808","article-title":"Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces","volume":"510","author":"S Gazzin","year":"2008","journal-title":"J Comp Neurol"},{"key":"pone.0238301.ref033","first-page":"13","article-title":"Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels","author":"CP Schaefer","year":"2018","journal-title":"PLoS One"},{"key":"pone.0238301.ref034","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1177\/0271678X17739219","article-title":"Executive dysfunction and blockage of brain microvessels in a rat model of vascular cognitive impairment","volume":"38","author":"KD Langdon","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"pone.0238301.ref035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ana.24992","article-title":"Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia","volume":"82","author":"H Ly","year":"2017","journal-title":"Ann Neurol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T13:32:12Z","timestamp":1599139932000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238301"}},"subtitle":[],"editor":[{"given":"M\u00e1ria A.","family":"Deli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238301","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}